Community Health Systems financials
$2.93+1.21%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.27B | $3.09B | $3.14B | $3.14B | $12.49B | $0.00 |
| Gross profit | $2.42B | $2.52B | $2.66B | $2.63B | $2.66B | $2.67B | $2.76B | $2.62B | $2.66B | $2.65B | $10.50B | $0.00 |
| Gross margin | 85.8% | 85.1% | 85.6% | 85.1% | 85.0% | 84.5% | 84.5% | 84.8% | 84.6% | 84.5% | 84.0% | — |
| Operating income | $389.0M | $281.0M | $450.0M | $243.0M | $512.0M | $284.0M | $278.0M | -$205.0M | $238.0M | $231.0M | $957.0M | $0.00 |
| Net income | $70.0M | -$58.0M | $110.0M | $130.0M | $282.0M | -$13.0M | -$70.0M | -$391.0M | -$13.0M | -$41.0M | -$133.0M | $0.00 |
| Net margin | 2.5% | −2.0% | 3.5% | 4.2% | 9.0% | −0.4% | −2.1% | −12.7% | −0.4% | −1.3% | −1.1% | — |
| Diluted EPS | $0.51 | $-0.43 | $0.80 | $0.96 | $2.09 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $-0.34 | $0.00 |
| EBITDA | $325.0M | $305.0M | $395.0M | $370.0M | $379.0M | $365.0M | $414.0M | $178.0M | $374.0M | $363.0M | $870.0M | $129.0M |
| Operating cash flow | $88.0M | -$297.0M | $266.0M | $69.0M | $88.0M | $120.0M | $216.0M | $67.0M | $101.0M | $96.0M | $90.0M | $29.0M |
| Free cash flow | $12.0M | -$373.0M | $172.0M | $4.0M | -$3.0M | $35.0M | $107.0M | -$3.0M | $13.0M | $3.0M | -$20.0M | -$101.0M |
| Diluted shares | 136.5M | 134.4M | 137.1M | 135.2M | 134.9M | 132.9M | 132.4M | 132.4M | 132.3M | 131.3M | 392.1M | — |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $149.0M | $712.0M | $260.0M | $123.0M | $456.0M | $431.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $9.78B | $10.33B | $10.63B | $10.81B | $11.08B | $11.53B |
| Total assets | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B |
| Total liabilities | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B |
| Shareholders' equity | -$1.16B | -$1.23B | -$1.16B | -$1.27B | -$1.41B | -$1.69B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology